Reuters logo
BRIEF-Bausch + Lomb, Nicox resubmit US NDA for Latanoprostene Bunod
February 27, 2017 / 6:36 AM / 7 months ago

BRIEF-Bausch + Lomb, Nicox resubmit US NDA for Latanoprostene Bunod

Feb 27 (Reuters) - Nicox Sa

* Bausch + Lomb and Nicox resubmit US New Drug Application for novel glaucoma candidate Latanoprostene Bunod

* Data submitted in NDA support Latanoprostene Bunod as first nitric-oxide donating prostaglandin f2α analog for ophthalmic use Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below